Congenica Blog Congenica selected for final phase of Instand-NGS4P
Cambridge, United Kingdom – 21 May, 2024 – Congenica, a UK-based digital health company specialising in innovative software and solutions for genomic data analysis and interpretation, is pleased to announce its selection for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology.
Read full article »
Congenica is an England-based digital health company that offers solutions such as AI-powered clinical decision support and genomic data analysis for the healthcare industry.
Read more